Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30028657

Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Sep 1
First author
Attard G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Attard G
      type
      Author
    2. name
      Borre M
      type
      Author
    3. name
      Gurney H
      type
      Author
    4. name
      Loriot Y
      type
      Author
    5. name
      Andresen-Daniil C
      type
      Author
    6. name
      Kalleda R
      type
      Author
    7. name
      Pham T
      type
      Author
    8. name
      Taplin ME
      type
      Author
    9. name
      PLATO collaborators
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Attard G
      type
      Author
    2. name
      Borre M
      type
      Author
    3. name
      Gurney H
      type
      Author
    4. name
      Loriot Y
      type
      Author
    5. name
      Andresen-Daniil C
      type
      Author
    6. name
      Kalleda R
      type
      Author
    7. name
      Pham T
      type
      Author
    8. name
      Taplin ME
      type
      Author
    9. name
      PLATO collaborators
      type
      CollectiveName
    bibliography ids
    1. nci-bib-c96a1ee8fb3625079064321d
    book metadata
    content sha256
    cd60df7082cfbf6e2c3a8df1952c929acf4f554bc098d27d17a36ab61174cb62
    document type
    citation
    dois
    1. 10.1200/JCO.2018.77.9827
    electronic publication date
    display
    2018 Jul 20
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30028657
    immutable id
    pubmed:30028657@cd60df7082cfbf6e2c3a8df1952c929acf4f554bc098d27d17a36ab61174cb62
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    25
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2639-2646
    volume
    36
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30028657
      provenance
      batch id
      c4c0356d060413f719c2
      provider
      NCBI PubMed ESummary
      record sha256
      99b7cac08454aab35bff4cb7eba48e14d70dfb7ef5e65a83b568fd3cb4410a15
      response sha256
      adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
      retrieved at
      2026-09-09T23:47:33.674758+00:00
      publication date
      display
      2018 Sep 1
      precision
      day
      year
      2018
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30028657/
      title
      Abiraterone Alone or in Combination With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer With Rising Prostate-Specific Antigen During Enzalutamide Treatment.

      Preserved source evidence · Not medical advice